Cargando…
Autopsy Analysis may Contribute to Establish Actual Incidence of Second Primary Malignancies in Myeloma
Second primary malignancies (SPMs) are issues for patients with multiple myeloma (MM). There may have been some limitations in prior studies, such as difficulties in a longer follow-up and absence of established screening methods. Therefore, we studied autopsied cases to overcome these limitations....
Autores principales: | Takano, Junichiro, Hagiwara, Shotaro, Miwa, Akiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703915/ https://www.ncbi.nlm.nih.gov/pubmed/26788269 http://dx.doi.org/10.4081/rt.2015.5949 |
Ejemplares similares
-
Large Plasmacytoma Occupying the Upper Limb in a Myeloma Patient
por: Takano, Junichiro, et al.
Publicado: (2017) -
Second Primary Malignancies and Myeloma Therapy: Fad or Fact?
por: Usmani, Saad Z.
Publicado: (2012) -
Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients
por: Avivi, Irit, et al.
Publicado: (2023) -
Second Primary Malignancy Risk in Multiple Myeloma from 1975 to 2018
por: Wang, Jing, et al.
Publicado: (2022) -
Comparison of (11)C-4′-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma
por: Okasaki, Momoko, et al.
Publicado: (2014)